ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
5,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
7,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
7,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
9,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
9,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
11,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
12,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
13,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,1,Prothrombin level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
15,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
17,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
19,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
19,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
19,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
21,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
22,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
24,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
24,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
26,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
26,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
27,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
29,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
29,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
31,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
32,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
34,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
36,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
37,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
38,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
39,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
39,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
41,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
42,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
44,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
45,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
46,1,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
47,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
48,1,Cross sensitivity reaction,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
48,2,Fixed eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
49,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
50,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
50,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
50,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
50,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
50,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
50,6,Headache,Headaches NEC,Headaches,Nerv,N
50,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
50,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
51,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
52,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,2,Increased viscosity of bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
52,3,Sputum increased,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
53,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
54,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
54,2,Madarosis,Alopecias,Skin appendage conditions,Skin,N
55,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
55,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
55,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
56,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
57,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
58,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
58,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
58,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
59,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
59,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
59,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
59,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
59,7,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
60,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
61,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
62,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
63,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
64,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
64,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
65,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
66,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
67,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
68,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
68,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
69,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
71,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
71,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
71,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
71,6,Headache,Headaches NEC,Headaches,Nerv,N
71,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
71,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,1,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
72,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
73,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
74,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
75,1,Cystic fibrosis lung,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
76,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
77,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
78,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
78,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
78,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
79,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
80,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
80,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
80,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
85,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
85,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
86,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
86,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
87,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
89,1,Bronchopulmonary aspergillosis allergic,Aspergillus infections,Fungal infectious disorders,Infec,N
89,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
90,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
90,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
91,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
92,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
93,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
94,1,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
94,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
95,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
95,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
96,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
96,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
96,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
97,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
98,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
99,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
100,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
101,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
103,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
105,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
106,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
107,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
107,2,Deafness,Hearing losses,Hearing disorders,Ear,N
107,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
110,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
110,2,Deafness,Hearing losses,Hearing disorders,Ear,N
110,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
110,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
112,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
112,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
113,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
113,2,Deafness,Hearing losses,Hearing disorders,Ear,N
113,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
113,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
113,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
114,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
115,1,Blood iron abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
115,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
115,3,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
116,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
116,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
117,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
118,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
118,3,Headache,Headaches NEC,Headaches,Nerv,N
119,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
120,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,Y
120,4,Pneumonia pseudomonal,Pseudomonal infections,Bacterial infectious disorders,Infec,N
121,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
122,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
123,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,Y
124,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
126,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
131,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
136,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
137,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
138,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
140,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
140,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
141,1,Clostridium test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
142,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
143,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
144,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
145,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
